This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Rinuagene Biotechnology Co., Ltd., Rinuagene International Hk Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations and Contributions of Inventor Shan Cen
Introduction
Shan Cen is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of lipid compounds and polynucleotide molecules. With a total of 3 patents to his name, his work has the potential to impact various medical applications.
Latest Patents
One of Shan Cen's latest patents involves lipid compounds and lipid nanoparticle compositions. This patent discloses a compound of formula (I) and its salts and stereoisomers, along with a nanoparticle composition that utilizes these compounds for delivering active agents. Another significant patent focuses on polynucleotide molecules that can be used for the prevention or treatment of HPV infection-related diseases. This application relates to a polynucleotide molecule that can be incorporated into pharmaceutical products, compositions, or mRNA vaccines aimed at combating HPV-related health issues.
Career Highlights
Shan Cen has worked with Rinuagene Biotechnology Co., Ltd. and Rinuagene International HK Limited, where he has contributed to various innovative projects. His expertise in biotechnology has allowed him to develop solutions that address critical health challenges.
Collaborations
Shan Cen has collaborated with notable professionals in his field, including Yijie Dong and Kai Lv. These collaborations have further enhanced his research and development efforts.
Conclusion
Shan Cen's innovative work in biotechnology, particularly in lipid compounds and polynucleotide molecules, showcases his commitment to advancing medical science. His contributions are poised to make a significant impact on the prevention and treatment of diseases, particularly those related to HPV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile